Title | CRM2DIM: Dual-Agent Bayesian Continual Reassessment Method (SAS) |
Publication Type | Software |
Year of Publication | 2019 |
Authors | Bayar, Mohamed, Anastasia Ivanova, and Gwenael Le Teuff |
Version | 1.0 |
Abstract | The continual reassessment method (CRM) is a model-based dose-finding design for single-agent phase I oncology trials. With the advance of targeted therapies in oncology, more and more phase I trials investigate drug combinations |
Project:
Software Weblinks: